Stoneridge, Inc. (SRI) Misses Q1 EPS by 5c, Reaffirms FY11 Sales Guidance
Tweet
Share
E-mailGet Alerts SRI Hot Sheet
Price: $7.19 --0%
Financial Fact:
Diluted net income per share: 0.36
Today's EPS Names:
GNLN, USDP, AFIB, More
Financial Fact:
Diluted net income per share: 0.36
Today's EPS Names:
GNLN, USDP, AFIB, More
Join SI Premium – FREE
Stoneridge, Inc. (NYSE: SRI) reported Q1 EPS of $0.14, $0.05 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $190.4 million versus the consensus estimate of $190.2 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Traws Pharma (TRAW) Tops Q2 EPS by 27c
- Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c
- Paramount Global (PARA) Tops Q2 EPS by 480c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
